chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Low platelets; Rash all over his torso and neck; Fever that is close to 103 degrees Fahrenheit; rash all over his torso and neck was reported as worsened; This is a spontaneous report from a contactable consumer (patient). A 54-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EN6198), via an unspecified route of administration in the left arm (shoulder) on 20Feb2021 at 11:00 (at the age of 54-years-old) as dose 2, single for COVID-19 immunization. The patient medical history was not reported. There were no concomitant medications. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EL9265), via an unspecified route of administration in the right arm (shoulder) on 30Jan2021 at 13:00 as dose 1, single for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Patient reported that he had the 2nd dose maybe 5-6 weeks ago and that past week he was experiencing some unusual things and did not know if they were related to the vaccine. Patient stated that out of nowhere he had that fever that was close to 103 degrees Fahrenheit and the fever began on 27Mar2021, he had low blood platelets and the test was done on 29Mar2021 with his platelet count 91,000. Patient further stated he had a rash all over his torso and neck and stated those were the main things and rash all over his torso and neck was reported as worsened (2021). The events resulted in physician, emergency room and urgent care visit. The patient underwent lab tests and procedures which included body temperature: 103 degree fahrenheit on 27Mar2021 and platelet count: low;91,000 on 29Mar2021. The clinical outcome for the events, rash all over his torso and neck and fever that is close to 103 degrees Fahrenheit was not recovered and unknown for low platelets and rash all over his torso and neck was reported as worsened.   No follow-up attempts are possible. No further information is expected.
Fever of 100.4; This is a spontaneous report from a contactable consumer or other non hcp (Patient's father). A 12-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0217 and expiration date was not given), via an unspecified route of administration on 10Jun2021, as 2nd dose, single dose for covid-19 immunisation. Patient's medical history and concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number and expiration date was not given) for COVID-19 immunisation on an unspecified date. On 11Jun2021 patient experienced fever of 100.4. It was reported that, the reporter enquired My daughter got the second dose of the Pfizer on Thursday and today she has a fever of 100.4 and I was wondering if she could take Aleve. The patient underwent lab tests and procedures which included body temperature: 100.4 on 11Jun2021. The outcome of the event was unknown.
Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Allergic: Rash Generalized-Medium
Mom called 4/27/11 to our clinic to report that pt's LD was very swelling/red/warm to touch. Advise mom to start putting ice to the affected area & give TYLENOL for discomfort. Mom also reported that child was moving arm w/o problem. Also mom was advised to take him to ER if sx worsen. Pt was treated with 1 dose cephalexin & 1 dose BENADRYL in ED on 4/27/11. Improving by next day.
This spontaneous report as received from a consumer refers to an unspecified number of patients of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On unknown dates, the patients were vaccinated with the doses of ZOSTAVAX (dose, route of administration, lot # and expiration date were not reported). On unknown dates, the patients came down with a mild case of shingles. The outcome of herpes zoster was unknown. The relatedness between the adverse events and the vaccination with ZOSTAVAX was not reported. Additional information has been requested.
Awoke at 11pm from a sound sleep feeling unusual but unable to identify anything specific. Checked my O2 saturation with my pulse ox and was 76% with a heart rate of 122.  Used my rescue albuterol inhaler which I haven't used since October (Fall and Spring are my typical times when I need albuterol inhaler and then not regular use.) Waited 15 mins with no change.  Took a nebulizer treatment of albuterol.  After 30 minutes was getting O2 saturations in the 80's. With deep breaths after an hour got a reading of 96% but wasn't consistently staying in the 90's.  Fell back asleep around midnight and awoke feeling ok.  I did not feel SOB when my saturation was at 76%, but my pulse was elevated to help compensate.
1st dose 2018, 2nd not yet; muscle aches; pain, soreness of the rotator cuff; headaches; nausea; This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included shingles and allergy to insect sting.   On an unknown date, the patient received the 1st dose of Shingrix and did not receive the 2nd dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced muscle pain, pain, headache, nausea and incomplete course of vaccination. On an unknown date, the outcome of the muscle pain, pain, headache and nausea were recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the muscle pain, pain, headache and nausea to be related to Shingrix.     Additional Information: GSK receipt date: 8-Nov-2022 Reporter's comment: The patient received his first dose of Shingrix in 2018 but never received his second dose. The patient stated that when he received this dose he experienced muscle aches, pain, headaches, nausea and soreness in his rotator cuff.  The patient stated that these started day after the administration and continued for four days. The patient stated that he plan to get the second dose as soon as possible. The reporter consented to follow-up. Additional supportive information: Till the time of reporting, the patient did not receive the second dose of Shingrix, which led to incomplete course of vaccination.
6-4-08 OV FTF complained redness, swelling, pain to left deltoid area approximately 2 inches wide - X 6 inches long, red, warm to touch - referred to PMD.
Initial report received from a healthcare professional on 05 October 2012. A female patient whose medical history and concomitant medications were not reported, had received an intradermal dose of FLUZONE ID vaccine (lot number UT4464AA, site of administration were not reported) on an unspecified date. On an unspecified date, the patient complained of left shoulder pain, extremity heaviness, numbness, dizziness more than two weeks and severity of pain was reported as 7/10. Corrective treatment and laboratory investigations were not reported. The patient's outcome was not reported. Documents held by sender: none.
Developed Shingles lesions on my right lower leg.  Blisters/vesicles.  I noticed this at 1:00am Thursday, February 4, 2021.  Went to my local Urgent Care facility on Thursday , 2/4/21 morning, 9:20am.  Diagnosed with Shingles.  Prescribed Valacyclovir 1gm BID.  Started first dose on Thursday, 2/4/21 at approx. 10:45am.   Currently experiencing burning sensation in the area of lesions.  Swollen lymph node in right groin area with pain/ache feeling surrounding the right groin lymph node.
At the time of my COVID-19 vaccine on March 31st, I was nearly 27 weeks pregnant with my second child. Eleven weeks later on June 16th I went into the doctor for a routine sonogram to discover the baby no longer had a heartbeat and the next day (June 17) she was delivered stillborn.
Localized redness, swelling and pain in arm. BENADRYL and  TYLENOL.
Narrative:  The patient received two doses of Pfizer COVID 19 vaccine in March 2021. The patient tested positive for COVID 19 on 28 Dec 21 and was admitted with HTN urgency potentially due to severe n/v from COVID 19. The patient was treated with hydralazine, ondansetron, and fluid replacement.
Client sat down shortly after receiving covid 19 vaccination. Slipped off of chair.  A/O x3 with no loss of consciousness. Denies any injury.  BP100/78 81 hr and 98% oximeter.  Assisted to cot until the dizziness subsided.  Encouraged to eat granola bar and water and retook vs prior to discharging after 30 minutes.  124/72 bp-97% and 61 hr.
Received both doses of the Pfizer covid vaccine early on and they all got covid 19; Received both doses of the Pfizer covid vaccine early on and they all got covid 19; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 5 patients. This is the first of five reports.   An elderly patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), 1st dose via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a single dose, 2nd dose via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received both doses of the Pfizer covid vaccine early on and the patient got covid 19 on an unspecified date. The outcome of the event was unknown.   The lot number for BNT162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101145699 Same Reporter/Drug/AE, Different Patient;US-PFIZER INC-202101145698 Same Reporter/Drug/AE, Different Patient;US-PFIZER INC-202101145696 Same Reporter/Drug/AE, Different Patient;US-PFIZER INC-202101145697 Same Reporter/Drug/AE, Different Patient;US-PFIZER INC-202101145699 Same Reporter/Drug/AE, Different Patient;US-PFIZER INC-202101145698 Same Reporter/Drug/AE, Different Patient
Sudden spreading rash; small itchy bumps, up vaccine arm and hands.; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 14:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included GERD (reported as recovered). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 00:30, the patient experienced sudden spreading rash, small itchy bumps, up vaccine arm and hands.  The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sudden spreading rash and small itchy bumps, up vaccine arm and hands was recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
My arm started hurting again on Saturday/Sunday. It was also getting a bit itchy and I noticed red dots around it. On Monday my arm was hurting and warm to the touch. It was also a bit swollen and itchy. It?s now Wednesday and my arm has a red circle and super itchy.
Pt states that area was swollen the size of a golf ball, red and very sore. Pt's physician thought area was excessively swollen for shot. Area checked with some swelling this date and heat. Advised heat and Ibuprofen to reduce both. Pt understood. Some lingering soreness.
Dizziness, swelling of throat, difficulty breathing.  Immediately give 50 mg Benadryl.  Have been taking Benadryl (25 mg) every 4 hours as well as Zantac 150 mg every 12 hours.
Approximately 16 hours after the vaccination my right arm turn cyanotic  and cold with delayed cap refill followed by extreme pain on movement and touch. Cyanosis resolved in a few hours, extreme pain on movement and touch resolved 24 hours after the initial onset.
This spontaneous report was received from a pharmacist refers to a female patient of unknown age. No relevant history of the patient was reported. On 27-JUN-2014 the patient was vaccinated with PNEUMOVAX 23, subcutaneous (strength, dose, lot number and expiration dates were not reported) instead of a purified protein derivative (PPD). No concomitant medications were reported. On 27-JUN-2014, shortly after PNEUMOVAX 23 the patient developed a red induration on the vaccinated arm and the arm was swollen to the elbow. It was unspecified if the patient had sought any medical attention. There was no intervention done to prevent the seriousness criteria. There was not product quality complaint (PQC) involved. The outcome of patient developed a red induration on the vaccinated arm and the arm was swollen to the elbow was reported as not recovered. The causality of the event patient developed a red induration on the vaccinated arm and the arm was swollen to the elbow was unknown. Additional information has been requested.
Palm size area rash at injection site 8 days after injection. Itchy, raised, red and warm. Still active today but appears to be diminishing. Ice pack applied.
Complaint of chills, sore/scratchy throat, and headache. Boyfriend and daughter both tested positive, subject had a positive test followed by a negative test the following day.
Temperature has gone up to 99.9, It is raising up again this afternoon like 99.5, It is not super high; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 56-years-old male patient received first dose of bnt162b2 ((PFIZER-BIONTECH COVID -19 VACCINE, Solution for injection, Batch/Lot number and Expiry date was not reported) via an unspecified route of administration, administered in left arm on an unspecified date as dose 1, single for COVID-19 immunization (age at vaccination: 56-years-old). Medical history included asthma from 2018 to an unknown date, and hypertension (last 30 years). Concomitant medications included atenolol and losartan taken for hypertension, budesonide, formoterol fumarate (SYMBICORT) taken for asthma from 2018 and ongoing. On 14Mar2021 the patient experienced temperature has gone up to 99.9, it is raising up again this afternoon like 99.5, it is not super high. The patient took the vaccine to prevent from Corona Virus pandemic. The patient had not received treatment for the event. On 14Mar2021 the patient underwent lab tests and procedures which included body temperature: 99.9 and 99.5 (Temperature has gone up to 99.9, It is raising up again this afternoon like 99.5, It is not super high). The outcome of the event was not recovered.  No follow-up attempts are possible. Information about lot/ batch number cannot be obtained.
Intermittent shooting pains in right arm, soreness at injection site, no redness or swelling at site
Pt had a seizure (generalized) lasting 5-6 minutes occurred less than 24 hours after influenza vaccine administration. First time pt received this vaccine.
Patient received a flu and pneumonia vaccine on 10/24/02. On 10/29/02, he informed me his arm had swollen up and turned red over the previous few days. 10/29 Today he said it had subsided mostly but still a little swollen.
pt recvd vax;exp itching on both legs & arms & at inject site;also devel round,pus-filled bumps which disappeared by am;pt was tx w/ diphenhydramine;
Narrative: 71yo male patient self-presented to community emergency facility Emergency Notification Intake Date Presenting to the Facility:Nov 17, 2021 Hospital: Chief complaint: Sepsis with septic shock AFIB with RVR, Acute metabolic acidosis. Pt admitted. Pt then died on 11/27/21 at this hospital. Pt had received covid vaccines on 5/7, 6/5 & 6/24 (2021) from place not specified in chart. This death is not related to vaccines.
This spontaneous report as received from a pharmacist refers to a 60 year old patient. On 19-AUG-2017, the patient was vaccinated with ZOSTAVAX lot # M039452 for prophylaxis. Concomitant therapies included sterile diluent. On 19-AUG-2017, 1 day after onset of therapy the patient experienced incorrect product storage. On an unknown date, the patient experienced no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to ZOSTAVAX. Additional information is not expected. Sender's Comments: US-009507513-1708USA012397: US-009507513-1708USA012398: US-009507513-1708USA012396: US-009507513-1707USA007162: US-009507513-1708USA012394: US-009507513-1708USA012395.
Tachycardia, SOB, low O2 saturation, syncope, chest heaviness.
Burning sensation.  Very red & raised rash and hives began to develop, particularly on arms
Zostavax given to 4 1/2 year old child rather than ProQuad. Parents advised to watch for redness, swelling at injection site, C pox rash in 1-3 weeks. Return child to clinic in 3 months for Varicella vaccine.
Palms looked like black blue tie dye; Twinge twice in left breast; shoulder pain above injection site; A spontaneous report was received from a consumer concerning a 79-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced shoulder pain above injection site, twinge twice in left breast and palms looked like black blue tie dye.  The patient's medical history included lumpectomy and chemotherapy. No relevant concomitant medications were reported.  On 22 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (029L20A) intramuscularly in the shoulder for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced shoulder pain above injection site, twinge twice in left breast and palms looked like black blue tie dye.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  On an unknown date, the event palms looked like black blue tie dye was resolved. The outcome of the events shoulder pain above injection site and twinge twice in left breast was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Patient reported swelling from right deltoid to right elbow. Red and warm to the touch. Reported morning after injection.
On second day received a rash covering face it went away within couple of days exactly two weeks late the same rash came but but worse
t104 mom gave pt APAP placed in warm tub of water; temp rechecked p/15 mins & it was 105.9 then;
headache, whole body joint pain, whole body muscle pain, fatigue, bruising and pain at injection site plus pain around site, left calf pain and weakness which increased one week later after taking a walk outside
Patient had a low muscle mass and appears that a blood vessel may have been nicked by the needle. After pulling the needle out of arm after injection, notice the blood seeped out from the injection site spurted out at more force than the usual trickle.  The site of injection swelled into a little welt with a slight blue hue.  The patient reported mild pain locally at the site of the injection immediately after.  No further complaints or reports from the patient since that time.
Signs/Symptoms as described by patient: Day after injection - Entire shoulder was red and hot to the touch. Arm was very painful, could not lift arm nor sleep on it. Two days after injection - Injection site was dark purple. Three weeks after injection - Pain to arm with movement, unable to sleep on side of injection secondary to pain. Certain movements cause shooting pain from shoulder up to neck on the left side. Patient followed up with PCP.
her cardiolipin antibodies tested on 05Mar2021 and she had a 40 result; her Cardiolipin level was about 40, AbigM.; sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A 80 year-old female patient received bnt162b2 (BNT162B2), administration date 08Feb2021 (Batch/Lot number: unknown) at the age of 79 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "positive cardiolipin antibodies" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1,Single, Manufacturer unknown), for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "sore arm"; CARDIOLIPIN ANTIBODY (non-serious) with onset 08Feb2021, outcome "unknown", described as "her Cardiolipin level was about 40, AbigM."; CARDIOLIPIN ANTIBODY POSITIVE (non-serious) with onset 05Mar2021, outcome "unknown", described as "her cardiolipin antibodies tested on 05Mar2021 and she had a 40 result". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: She got her booster dose of Pfizer Biontech COVID-19 vaccine on 22Sep2021. After the booster dose, she got tested again on 27Oct2021 and got a level of 102.1 which she refers to as "quite high". Her physician told her not to worry. Asks if there are any reports of a rise in cardiolipin antibodies caused by the vaccine. She called to report that her cardiolipin antibodies went up after the COVID booster higher than normal. She was taking blood test after the second dose, and booster dose. After the booster dose, her cardiolipin went up high. She also mentioned a sore arm. She didn't really say when she got the sore arm. She said it was a minimal condition. The caller confirmed some of the details provided by the transferring agent. This didn't occur after the second COVID dose. Her cardiolipin IgM levels 102.1. Which was quite high. It was a little higher which was concerning to her. She knows cardiolipins can be a problem with blood clotting. Caller declined health care provider information. She must leave at a quarter to two. She doesn't have time to do this.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Receive the vaccine, got a rash in my chest and on my left arm. Looking like mosquito bites. Continue to itch. Sweating all over my body. Weak in the legs when standing. Shoulder pain radiating to neck. Running nose.
patient c/o of lightheadness O: pt AAO x 3; BP 134/100 P: 80 O2 99 good color; (-) distress A/P provided pt water, recheck BP in 10 min patient stable; BP 130/100  discharged pt to home with husband